1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients

Cancer Biology and Therapy

Volumn 6, Issue 12, 2007, Pages 1847-1852

  Alfonso, Saily ^a   Diaz, Rosa M ^b   De La Torre, Ana ^a   Santiesteban, Eduardo ^c   Aguirre, Frank ^c   Pérez, Kirenia ^a   Rodríguez, José L ^a   Barroso, María Del Carmen ^b   Hernández, Ana M ^b   Toledo, Darien ^b   Gabri, Mariano R ^d   Alonso, Daniel F ^d   Viada, Carmen ^b   Gómez, Roberto E ^e   Suárez, Eduardo ^b   Vazquez, Ana M ^b   Perez, Rolando ^b   Macias, Amparo E ^b  

^a Cardiocentro Ernesto Che Guevara Hospital Celestino Hernández Robau   (Cuba)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^c José R López Tabrane Hospital   (Cuba)

^d UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^e ELEA Laboratories   (Argentina)

Author keywords

Anti idiotype antibody; Cancer vaccines; Clinical study; Immunotherapy

Indexed keywords

ALUMINUM HYDROXIDE; ANTIIDIOTYPIC ANTIBODY; CANCER VACCINE; MONOCLONAL ANTIBODY 1E10;

ADULT; AGED; ARTHRALGIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; ERYTHEMA; FEMALE; FEVER; HEADACHE; HUMAN; HYPERTENSION; INJECTION SITE INDURATION; INJECTION SITE PAIN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRURITUS; SURVIVAL TIME;

EID: 42549128373     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.12.5000     Document Type: Article

References (58)